Production (Stage)
Wellgistics Health, Inc.
WGRX
$2.36
-$0.12-4.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -648.67% | -132.02% | -366.52% | -381.59% | 92.28% |
| Total Depreciation and Amortization | 11.97% | 101.81% | 2,752.34% | -- | -- |
| Total Amortization of Deferred Charges | -- | -200.00% | -- | -- | -- |
| Total Other Non-Cash Items | 2,326.35% | 4,198.88% | -- | -- | -- |
| Change in Net Operating Assets | 2,060.05% | -104.53% | 447.98% | 332.52% | -81.37% |
| Cash from Operations | 49.34% | -300.63% | 1,135.41% | 243.91% | 106.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 1,111.12% | -426.40% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.00% | 25.56% | -203.64% | -- | -- |
| Cash from Investing | -132.57% | 365.40% | -664.89% | -241.32% | -- |
| Total Debt Issued | -47.55% | -- | -- | -- | -28.57% |
| Total Debt Repaid | -356.67% | 152.10% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 0.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -884.72% | -- | -- | -- | -- |
| Cash from Financing | 51.18% | 825.36% | -2,935.00% | -96.15% | -25.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 532.74% | -67.61% | 854.27% | -73.87% | 359.77% |